BET bromodomain degradation as a therapeutic strategy in drug-resistant multiple myeloma

被引:1
|
作者
Matthews, Geoffrey M.
Hu, Yiguo
Sheffer, Michel
Hengeveld, Paul J.
Buckley, Dennis L.
Bariteau, Megan A.
Poarch, Haley
Bradner, James E.
Mitsiades, Constantine S.
机构
关键词
D O I
10.1158/1538-7445.AM2016-4713
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4713
引用
收藏
页数:3
相关论文
共 50 条
  • [1] BET Bromodomain Degradation As a Therapeutic Strategy in Multiple Myeloma
    Matthews, Geoffrey M.
    Gandolfi, Sara
    Bruggentheis, Johanna
    Simoes, Ricardo De Matos
    Buckley, Dennis L.
    Hu, Yiguo
    Sheffer, Michal
    Poarch, Hayley
    Bradner, James E.
    Mitsiades, Constantine S.
    BLOOD, 2016, 128 (22)
  • [2] Cdc42: A New therapeutic target in drug-resistant multiple myeloma
    Thi Thuy Phuong Nguyen
    Chakrabart, Jayati
    Guo, Fukun
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [3] Combined treatment for drug-resistant multiple myeloma?
    Burton, A
    LANCET ONCOLOGY, 2005, 6 (07): : 447 - 447
  • [4] SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma
    Wu, Jian
    Zhang, Min
    Faruq, Omar
    Zacksenhaus, Eldad
    Chen, Wenming
    Liu, Aijun
    Chang, Hong
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [5] SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma
    Jian Wu
    Min Zhang
    Omar Faruq
    Eldad Zacksenhaus
    Wenming Chen
    Aijun Liu
    Hong Chang
    Biomarker Research, 9
  • [6] Selective BET bromodomain inhibition as an antifungal therapeutic strategy
    Mietton, Flore
    Ferri, Elena
    Champleboux, Morgane
    Zala, Ninon
    Maubon, Daniele
    Zhou, Yingsheng
    Harbut, Mike
    Spittler, Didier
    Garnaud, Cecile
    Courcon, Marie
    Chauvel, Murielle
    d'Enfert, Christophe
    Kashemirov, Boris A.
    Hull, Mitchell
    Cornet, Muriel
    McKenna, Charles E.
    Govin, Jerome
    Petosa, Carlo
    NATURE COMMUNICATIONS, 2017, 8
  • [7] Selective BET bromodomain inhibition as an antifungal therapeutic strategy
    Flore Mietton
    Elena Ferri
    Morgane Champleboux
    Ninon Zala
    Danièle Maubon
    Yingsheng Zhou
    Mike Harbut
    Didier Spittler
    Cécile Garnaud
    Marie Courçon
    Murielle Chauvel
    Christophe d’Enfert
    Boris A. Kashemirov
    Mitchell Hull
    Muriel Cornet
    Charles E. McKenna
    Jérôme Govin
    Carlo Petosa
    Nature Communications, 8
  • [8] Combination therapy for treating drug-resistant multiple myeloma
    Kim, Byung-Gyu
    Choi, Sung Hee
    Luo, George
    Kim, Seong-Jin
    Malek, Ehsan
    Driscoll, James
    Letterio, John
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [9] Updates to the drug-resistant mechanism of proteasome inhibitors in multiple myeloma
    Bai, Yang
    Su, Xing
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (01) : 29 - 35
  • [10] Perspectives for combination therapy to overcome drug-resistant multiple myeloma
    Catley, L
    Tai, YT
    Chauhan, D
    Anderson, KC
    DRUG RESISTANCE UPDATES, 2005, 8 (04) : 205 - 218